Breaking News Instant updates and real-time market news.

HUM

Humana

$167.24

-10.295 (-5.80%)

, AET

Aetna

$109.83

-2.24 (-2.00%)

14:26
10/12/16
10/12
14:26
10/12/16
14:26

Humana CMS star rating news shouldn't impact Aetna deal, says Cantor

After Humana (HUM) reported that the Centers for Medicare and Medicaid Services reported that the percentage of the company's membership in 4-Star plans or higher declined to approximately 37% from approximately 78% in the prior year, Cantor analysts said they do not expect the news to impact 2017 enrollment or the pending Aetna (AET) deal. The firm reiterates its Buy rating and $225 price target on Humana shares.

HUM

Humana

$167.24

-10.295 (-5.80%)

AET

Aetna

$109.83

-2.24 (-2.00%)

  • 06

    Nov

  • 10

    Nov

HUM Humana
$167.24

-10.295 (-5.80%)

07/22/16
COWN
07/22/16
NO CHANGE
Target $160
COWN
Outperform
Cigna has greatest upside should DOJ block mergers, says Cowen
Cowen noted the DOJ tone toward the pending managed care deals is decidedly negative and raised the burden of proof on the companies to demonstrate the deals are not anti-competitive. Cowen believes Cigna has the most upside of the four companies involved whether the deals go through or not. Cowen has an Outperform rating and $160 price target on Cigna shares.
08/22/16
LEER
08/22/16
NO CHANGE
LEER
Leerink less positive that Anthem challenge to DOJ lawsuit will be successful
Following a conference call with an anti-trust specialist, Leerink analyst Ana Gupte is less positive that the Anthem (ANTM) challenge to the lawsuit by the DOJ will be successful. The analyst says that the specialist views the obstacles to a defense by Anthem-Cigna (CI) to the anti-trust concerns as too numerous to result in a successful close. Further, the analyst believes that any favorable decision, however unlikely, on the merger close, will likely be appealed by the DOJ. Nonetheless, the lower likelihood of this defense being successful may improve the odds of a successful Aetna (AET)-Humana (HUM) defense, the analyst notes.
08/25/16
COWN
08/25/16
NO CHANGE
COWN
Managed Care mergers unlikely to close, says Cowen
Cowen analyst Christine Arnold believes the current managed care mergers including Aetna (AET) and Humana (HUM) and Anthem (ANTM) and Cigna (CI) are unlikely to close. The analyst said the government's ability to appeal could extend the litigation process beyond the termination dates stipulated in the merger agreements. Arnold believes the Aetna/Humana merger has a better chance of closing relative to the Anthem/Cigna deal, but believes neither are likely to close.
09/22/16
EVER
09/22/16
INITIATION
EVER
Buy
Humana initiated with a Buy at Evercore ISI
AET Aetna
$109.83

-2.24 (-2.00%)

09/22/16
EVER
09/22/16
INITIATION
Target $128
EVER
Buy
Aetna initiated with a Buy at Evercore ISI
Evercore ISI analyst Michael Newshel initiated Aetna with a Buy and a $128 price target.
09/29/16
PACS
09/29/16
DOWNGRADE
PACS
Underweight
Pacific Crest cuts Fitbit to sell, sees share downside to $11
Pacific Crest analyst Brad Erickson downgraded Fitbit (FIT) to Underweight from Sector Weight after his channel checks indicated that Charge 2, the company's flagship holiday product, is off to a slow start. Underweight is Pacific Crest's equivalent of a sell rating. Charge 2 inventory is accumulating in the channel and sell-through is below initial Blaze/Alta levels, Erickson tells investors in a research note. The analyst continues to believe that a large portion of Fitbit owners stop using the device within months. Further, he views the corporate wellness deal between Aetna (AET) and Apple (AAPL) as a "substantial negative" for Fitbit. Erickson sees downside to $11 for shares of Fitbit. The stock closed yesterday up 17c to $16.70.

TODAY'S FREE FLY STORIES

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.